Westpac Banking Corp’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.5M Sell
9,928
-339
-3% -$72.9K 0.15% 133
2026
Q1
$2.23M Sell
10,267
-2,302
-18% -$511K 0.16% 135
2025
Q4
$2.87M Sell
12,569
-1,272
-9% -$290K 0.18% 119
2025
Q3
$3.2M Sell
13,841
-103
-0.7% -$21K 0.2% 117
2025
Q2
$2.59M Sell
13,944
-1,771
-11% -$329K 0.17% 127
2025
Q1
$3.29M Sell
15,715
-3,470
-18% -$675K 0.24% 106
2024
Q4
$3.41M Sell
19,185
-63
-0.3% -$11.6K 0.23% 110
2024
Q3
$3.8M Buy
19,248
+704
+4% +$131K 0.25% 104
2024
Q2
$3.18M Buy
18,544
+2,024
+12% +$335K 0.25% 104
2024
Q1
$3.01M Sell
16,520
-3,770
-19% -$650K 0.23% 112
2023
Q4
$3.14M Sell
20,290
-13,962
-41% -$2.04M 0.26% 105
2023
Q3
$5.11M Buy
34,252
+20,485
+149% +$3.01M 0.38% 59
2023
Q2
$1.85M Sell
13,767
-166,724
-92% -$24.4M 0.13% 185
2023
Q1
$28.8M Sell
180,491
-4,809
-3% -$735K 0.39% 49
2022
Q4
$29.9M Buy
185,300
+164
+0.1% +$25.1K 0.44% 38
2022
Q3
$24.8M Buy
185,136
+305
+0.2% +$43.8K 0.38% 50
2022
Q2
$28.3M Buy
184,831
+6,157
+3% +$941K 0.37% 51
2022
Q1
$29M Sell
178,674
-2,224
-1% -$323K 0.33% 66
2021
Q4
$24.5M Buy
180,898
+1,522
+0.8% +$180K 0.25% 98
2021
Q3
$19.3M Sell
179,376
-17,018
-9% -$1.94M 0.21% 120
2021
Q2
$22.1M Sell
196,394
-4,657
-2% -$524K 0.22% 109
2021
Q1
$21.8M Sell
201,051
-58
-0% -$6.2K 0.24% 105
2020
Q4
$21.5M Sell
201,109
-4,114
-2% -$395K 0.24% 108
2020
Q3
$18M Buy
205,223
+761
+0.4% +$71.6K 0.24% 99
2020
Q2
$20.1M Buy
204,462
+33,556
+20% +$2.95M 0.3% 81
2020
Q1
$13M Buy
170,906
+6,007
+4% +$512K 0.22% 122
2019
Q4
$14.6M Sell
164,899
-3,300
-2% -$274K 0.19% 143
2019
Q3
$12.7M Sell
168,199
-11,498
-6% -$788K 0.18% 159
2019
Q2
$13.1M Buy
179,697
+9,238
+5% +$726K 0.2% 134
2019
Q1
$13.7M Buy
170,459
+62,579
+58% +$5.12M 0.23% 121
2018
Q4
$9.95M Sell
107,880
-3,326
-3% -$292K 0.17% 165
2018
Q3
$10.5M Sell
111,206
-3,766
-3% -$357K 0.18% 161
2018
Q2
$10.7M Buy
114,972
+3,617
+3% +$353K 0.2% 138
2018
Q1
$10.5M Buy
111,355
+7,923
+8% +$870K 0.21% 137
2017
Q4
$10M Buy
103,432
+400
+0.4% +$37.7K 0.23% 131
2017
Q3
$9.16M Sell
103,032
-3,321
-3% -$253K 0.2% 143
2017
Q2
$7.71M Sell
106,353
-5,359
-5% -$360K 0.17% 156
2017
Q1
$7.28M Buy
111,712
+7,129
+7% +$448K 0.06% 318
2016
Q4
$6.38M Buy
104,583
+6,563
+7% +$401K 0.06% 338
2016
Q3
$6.18M Buy
98,020
+6,893
+8% +$446K 0.07% 319
2016
Q2
$5.64M Sell
91,127
-25,553
-22% -$1.56M 0.06% 346
2016
Q1
$6.66M Sell
116,680
-69,368
-37% -$3.87M 0.07% 274
2015
Q4
$11M Buy
186,048
+56,648
+44% +$3.26M 0.12% 187
2015
Q3
$7.04M Buy
129,400
+21,121
+20% +$1.37M 0.08% 242
2015
Q2
$7.28M Sell
108,279
-810,957
-88% -$52.9M 0.07% 246
2015
Q1
$60.8M Buy
919,236
+264,563
+40% +$16M 0.53% 31
2014
Q4
$42.8M Sell
654,673
-32,517
-5% -$2.05M 0.41% 44
2014
Q3
$39.7M Sell
687,190
-3,492
-0.5% -$194K 0.39% 48
2014
Q2
$39M Sell
690,682
-66,833
-9% -$3.51M 0.38% 49
2014
Q1
$38.9M Buy
757,515
+460,605
+155% +$23.3M 0.41% 52
2013
Q4
$15.7M Sell
296,910
-161,917
-35% -$7.96M 0.18% 149
2013
Q3
$20.5M Sell
458,827
-27,831
-6% -$1.23M 0.26% 96
2013
Q2
$19.9M Buy
+486,658
New +$21.3M 0.3% 86

Other funds holding ABBV

Westpac Banking Corp's ABBV Position: Q2 2026 in Review

Westpac Banking Corp reduced its AbbVie (ABBV) stake by 3.3% in Q2 2026, selling an estimated $72.9K and leaving 9,928 shares worth $2.5M. The position accounts for 0.15% of the portfolio, ranked #133.

Westpac Banking Corp first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $60.8M in Q1 2015. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Westpac Banking Corp held 9,928 shares of AbbVie worth $2.5M as of Q2 2026.
  • Westpac Banking Corp sold 339 AbbVie shares in Q2 2026, an estimated $72.9K.
  • AbbVie made up 0.15% of Westpac Banking Corp's portfolio in Q2 2026, its #133 holding.
  • Westpac Banking Corp first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
  • Westpac Banking Corp's AbbVie position peaked at $60.8M in Q1 2015.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Westpac Banking Corp's 13F filing for Q2 2026, filed 12 Aug 2026.